Suggested Topics within your search.
Suggested Topics within your search.
- Nurse and patient 1
- Nursing 1
- Practice 1
-
821
AhR Activation Transcriptionally Induces Anti-Microbial Peptide Alpha-Defensin 1 Leading to Reversal of Gut Microbiota Dysbiosis and Colitis
Published 2025-12-01Subjects: Get full text
Article -
822
The role of major virulence factors and pathogenicity of adherent-invasive Escherichia coli in patients with Crohn’s disease
Published 2020-12-01Subjects: Get full text
Article -
823
Individual-network based predictions of microbial interaction signatures for response to biological therapies in IBD patients
Published 2025-01-01Subjects: “…inflammatory bowel disease…”
Get full text
Article -
824
-
825
Colonic strictures in Crohn’s disease: a non-surgical survival
Published 2025-12-01Subjects: “…Inflammatory bowel disease…”
Get full text
Article -
826
The Mechanisms of Action of Interleukin-1 on Rabbit Intestinal Epithelial Cells
Published 1999-01-01Subjects: Get full text
Article -
827
A review of the types of diets used in Crohn’s disease: the support system for pharmacological treatment
Published 2025-01-01Subjects: Get full text
Article -
828
Regulation of nuclear factor-κB in intestinal epithelial cells in a cell model of inflammation
Published 2003-01-01Subjects: Get full text
Article -
829
Gastrointestinal complications of hepatic glycogen storage disease: a national survey questionnaire study in China
Published 2025-01-01Subjects: Get full text
Article -
830
SARS-CoV-2 vaccination in inflammatory bowel disease (IBD) patients – does treatment for IBD negatively affect SARS-CoV-2 antibodies?...
Published 2023-07-01Subjects: Get full text
Article -
831
Use of a Food Frequency Questionnaire for the Estimation of Gut Microbiota Composition Based on Dietary Patterns and Its Association with Irritable Bowel Syndrome Symptoms in the Lebanese Adult Population: A Cross-Sectional Study
Published 2024-01-01“…Emerging evidence suggests dysbiosis as a contributor to irritable bowel syndrome (IBS), but the results remain uncertain. …”
Get full text
Article -
832
Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome
Published 2016-01-01“…Although the differential expression of microRNA (miRNA) genes has been identified in many diseases, little information exists concerning the miRNA expression profile in type 2 diabetes mellitus (T2DM) with diarrhea-predominant irritable bowel syndrome (D-IBS). Therefore, the specific expression of miRNAs in diabetes with D-IBS is identified in the study. …”
Get full text
Article -
833
A Randomized, Endoscopist-Blinded, Prospective Trial to Compare the Efficacy and Patient Tolerability between Bowel Preparation Protocols Using Sodium Picosulfate Magnesium Citrate and Polyethylene-Glycol (1 L and 2 L) for Colonoscopy
Published 2020-01-01“…Patient compliance during bowel preparation is important for successful colonoscopy. …”
Get full text
Article -
834
Biosimilars in Focus: Evaluating Their Role Compared to Adalimumab in Clinical Practice
Published 2025-01-01Subjects: Get full text
Article -
835
Optimizing duodenal tissue acquisition for mechanistic studies of duodenal ablation in type 2 diabetes
Published 2025-01-01Subjects: Get full text
Article -
836
Small Intestinal Bacterial Overgrowth Syndrome as a Risk Factor for Ventricular Tachycardia in Chronic Heart Failure with Left Ventricular Systolic Dysfunction
Published 2019-06-01Subjects: “…small bowel bacterial overgrowth syndrome…”
Get full text
Article -
837
Engineering probiotic Escherichia coli for inflammation-responsive indoleacetic acid production using RiboJ-enhanced genetic circuits
Published 2025-01-01Subjects: Get full text
Article -
838
Intestinal permeability, food antigens and the microbiome: a multifaceted perspective
Published 2025-01-01Subjects: Get full text
Article -
839
-
840
Secukinumab-Induced Inflammatory Bowel Disease in a Patient Treated for Chronic Plaque Psoriasis and Psoriatic Arthritis: A Case Report and Review of the Role of Novel Biologic Agents Targeting the p19 Subunit of IL-23
Published 2020-01-01“…It was determined by the gastroenterologist that this may represent secukinumab-induced inflammatory bowel disease. We will review the current understanding of the role of IL-17 in inflammatory bowel disease and the important role of novel agents that target the p19 subunit of IL-23 which have shown significant promise in the management of not only chronic plaque psoriasis and psoriatic arthritis, but also inflammatory bowel disease itself.…”
Get full text
Article